TP53 and breast cancer: It is reported that AT-MSCs-derived MVs loaded with apoptosis-induced factors and substances can induce apoptosis and inhibit the proliferation of BC cells by upregulating Bax, P53, E2F2, and SMAD5 genes and downregulating the bcl gene [70].